Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Concomitant Radiochemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06170710
What this trial is testing

Postoperative CCRT Followed by Immunotherapy in High-Risk LA HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 173
Testing effectiveness (Phase 2)Study completedNCT04952597
What this trial is testing

Study of Ociperlimab Plus Tislelizumab Plus Chemoradiotherapy in Participants With Untreated Limited-Stage Small Cell Lung Cancer

Who this might be right for
Limited Stage Small Cell Lung Cancer
BeiGene 126
Testing effectiveness (Phase 2)Looking for participantsNCT06709417
What this trial is testing

A Phase II Clinical Study of Sintilimab Combined with Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC) (NICE-CS)

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Shanghai Chest Hospital 52
Not applicableUnknownNCT01646853
What this trial is testing

Radiation Dose Study of Concurrent Chemoradiotherapy With Cisplatin Plus Fluorouracil in Oesophageal Cancer

Who this might be right for
Esophageal Neoplasms
Simcere Pharmaceutical Co., Ltd 500
Testing effectiveness (Phase 2)Looking for participantsNCT06452602
What this trial is testing

Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy in Patients With ESCC.

Who this might be right for
Esophageal Cancer
Tianjin Medical University Cancer Institute and Hospital 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT06342167
What this trial is testing

Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell Carcinoma

Who this might be right for
Locally Advanced Esophageal Squamous Cell CarcinomaSintilimabRadiotherapy+2 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 57
Not applicableWithdrawnNCT02289807
What this trial is testing

Concurrent Chemotherapy in Intermediate Risk Patients Treated With Intensity-modulated Radiotherapy

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University
Testing effectiveness (Phase 2)Study completedNCT00203905
What this trial is testing

Chemoradiotherapy for Intermediate Stage/Selected Stage IV Cancers of the Head and Neck

Who this might be right for
Head and Neck Cancer
University of Chicago 23
Testing effectiveness (Phase 2)UnknownNCT02268006
What this trial is testing

IMRT-SIB and Capecitabine in Preoperative Rectal Cancer Treatment

Who this might be right for
Rectal Carcinoma
Institute of Oncology Ljubljana 50
Large-scale testing (Phase 3)Active Not RecruitingNCT02998385
What this trial is testing

Chemo-radiotherapy Versus Radiotherapy in the Treatment of Salivary Glands and Nasal Tumors (IMRT or Protontherapy)

Who this might be right for
HNSCC
Groupe Oncologie Radiotherapie Tete et Cou 342
Testing effectiveness (Phase 2)UnknownNCT04844385
What this trial is testing

Toripalimab Plus Neoadjuvant Chemotherapy Combined With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Sun Yat-sen University 124
Not applicableStudy completedNCT01261585
What this trial is testing

Study of the Fixation of Various Vectors in PET/CT in Patients With a With Lung Cancer Before and During of CRT or RT

Who this might be right for
Bronchial NeoplasmsCarcinoma, Non-Small-Cell Lung
Centre Henri Becquerel 5
Testing effectiveness (Phase 2)UnknownNCT05749042
What this trial is testing

Concurrent Chemoradiotherapy Based of Cisplatin With or Without Sintilimab as First-line Therapy for Patients With Advanced Oral Cavity Squamous Cell Carcinoma

Who this might be right for
Oral Cavity Squamous Cell Carcinoma
Xin-Hua Xu 70
Large-scale testing (Phase 3)Looking for participantsNCT07566156
What this trial is testing

Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)

Who this might be right for
Urothelial CancerUrinary Bladder Neoplasms
Astellas Pharma Global Development, Inc. 390
Large-scale testing (Phase 3)UnknownNCT02193594
What this trial is testing

Preoperative Concurrent Chemoradiotherapy for Locally Advanced Gastroesophageal Junction or Upper Gastric Adenocarcinoma

Who this might be right for
Gastroesophageal Junction Adenocarcinoma
Peking University 214
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06304545
What this trial is testing

Treatment of Rectal Cancer With Long-term Concurrent Chemoradiotherapy Combined With Camrelizumab

Who this might be right for
Rectal Cancer
Harbin Medical University 48
Post-approval studies (Phase 4)Study completedNCT00046969
What this trial is testing

Epoetin Beta in Treating Anemia in Patients With Cervical Cancer

Who this might be right for
AnemiaCervical Cancer
AGO Study Group 450
Testing effectiveness (Phase 2)Study completedNCT02075385
What this trial is testing

Swallowing Intervention During Radiochemotherapy on Head and Neck Cancer

Who this might be right for
Head Neck CancerSwallowing Disorders
Barretos Cancer Hospital 94
Testing effectiveness (Phase 2)Looking for participantsNCT07622797
What this trial is testing

Exploratory Clinical Study of Camrelizumab Combined With Concurrent Chemoradiotherapy as an Organ-preserving Strategy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Late-stage Resectable Esophageal Squamous Carcinoma
The First Affiliated Hospital of Henan University of Science and Technology 164
Testing effectiveness (Phase 2)Looking for participantsNCT06912074
What this trial is testing

Hypofractionated vs. Conventional Chemoradiotherapy After Induction Chemo-immunotherapy for Unresectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Sun Yat-sen University 134
Next Page